Study to Evaluate an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Study Title
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.
Teva Identifier
PM014
ClinicalTrials.gov Identifier
NCT00240032
Study Status
Completed
Trial Condition(s)
Multiple Sclerosis
Interventions
Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
10/01/2004 - 07/01/2006
Phase
Phase 4

Study Type

Interventional